Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $1.2 million.

  • Biomerica's Cost of Revenue fell 333.61% to $1.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.2 million, marking a year-over-year decrease of 1548.5%. This contributed to the annual value of $4.8 million for FY2025, which is 18.73% up from last year.
  • Biomerica's Cost of Revenue amounted to $1.2 million in Q4 2025, which was down 333.61% from $956000.0 recorded in Q3 2025.
  • Biomerica's Cost of Revenue's 5-year high stood at $6.0 million during Q1 2022, with a 5-year trough of $956000.0 in Q3 2025.
  • Moreover, its 5-year median value for Cost of Revenue was $1.2 million (2024), whereas its average is $1.9 million.
  • Per our database at Business Quant, Biomerica's Cost of Revenue soared by 34958.26% in 2022 and then tumbled by 8344.82% in 2023.
  • Quarter analysis of 5 years shows Biomerica's Cost of Revenue stood at $3.9 million in 2021, then tumbled by 70.84% to $1.1 million in 2022, then rose by 9.91% to $1.2 million in 2023, then decreased by 3.46% to $1.2 million in 2024, then decreased by 3.34% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q4 2025, $956000.0 for Q3 2025, and $993000.0 during Q2 2025.